GTS 21 dihydrochloride
(Synonyms: (3E)-3-[(2,4-二甲氧基苯基)亚甲基]-3,4,5,6-四氢-2,3'-联吡啶二盐酸盐,DMXB-A; DMBX-anabaseine) 目录号 : GC10913
GTS 21 dihydrochloride是一种选择性α7烟碱乙酰胆碱受体（α7-nAChR）的部分激动剂，具有抗炎和增强认知的活性。
Cas No.:156223-05-1
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
GTS 21 dihydrochloride is a selective partial agonist of the α7 nicotinic acetylcholine receptor (α7-nAChR), possessing anti-inflammatory and cognition-enhancing activities[1]. GTS 21 dihydrochloride also acts as an antagonist of the α4β2 nAChR (Ki=20nM) and the 5-HT3A receptor (IC50=3.1μM)[2]. GTS 21 dihydrochloride is utilized in research related to age-associated memory impairment (AAMI), Alzheimer's disease, schizophrenia, and acute lung injury[3-4].
In vitro, pretreatment of PC12 cells with GTS 21 dihydrochloride (3μM) for 10 minutes, followed by stimulation with ethanol (100mM) for 24 hours, significantly attenuated ethanol-induced cytotoxicity and suppressed the abnormal increase in intracellular calcium concentration[5]. In human renal tubular epithelial cells (HK-2), pretreatment with GTS 21 dihydrochloride (3–10μM) for 30 minutes prior to LPS (10μg/ml) stimulation for 24 hours significantly inhibited NF-κB nuclear translocation and the expression of the kidney injury marker NGAL, while also reducing the secretion of the chemokine CCL20, thereby mitigating macrophage migration and infiltration into renal tubular cells[6].
In vivo, in Leprdb/db mice aged 10-12 weeks, intraperitoneal administration of GTS 21 dihydrochloride (4mg/kg) twice a day for 8 weeks significantly improved renal function parameters, e.g. Blood Urea Nitrogen (BUN), creatinine, reduced levels of kidney injury markers (KIM-1, NGAL) and inflammatory cytokines (IL-6, HMGB-1), and alleviated glomerular mesangial matrix expansion and apoptosis[7]. In a septic acute kidney injury model induced by LPS (5mg/kg; i.p.) in C57BL/6J mice, a single pretreatment with GTS 21 dihydrochloride (20mg/kg; i.p.) 15 minutes prior to LPS challenge significantly lowered plasma TNF-α levels, BUN, and the expression of renal injury markers NGAL and KIM-1, while also reducing the number of apoptotic cells in kidney tissue[8].
References:
[1] Briggs CA, Anderson DJ, Brioni JD, et al. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav. 1997 May-Jun;57(1-2):231-41.
[2] Zhang R, White NA, Soti FS, et al. N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine. J Pharmacol Exp Ther. 2006 Jun;317(3):1276-84.
[3] Olincy A, Harris JG, Johnson LL, et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry. 2006 Jun;63(6):630-8.
[4] Adams CE, Stevens KE, Kem WR, et al. Inhibition of nitric oxide synthase prevents alpha 7 nicotinic receptor-mediated restoration of inhibitory auditory gating in rat hippocampus. Brain Res. 2000 Sep 22;877(2):235-44.
[5] Li Y, King MA, Grimes J, et al. Alpha7 nicotinic receptor mediated protection against ethanol-induced cytotoxicity in PC12 cells. Brain Res. 1999 Jan 16;816(1):225-8.
[6] Yang A, Wu CH, Matsuo S, et al. Activation of the α7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration. Int Immunopharmacol. 2024 Sep 10;138:112555.
[7] Nakamura Y, Matsumoto H, Wu CH, et al. Alpha 7 nicotinic acetylcholine receptors signaling boosts cell-cell interactions in macrophages effecting anti-inflammatory and organ protection. Commun Biol. 2023 Jun 23;6(1):666.
[8] Meng Q, Tian X, Li J, et al. GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb/db mice. Sci Rep. 2022 Dec 26;12(1):22360.
GTS 21 dihydrochloride是一种选择性α7烟碱乙酰胆碱受体（α7-nAChR）的部分激动剂，具有抗炎和增强认知的活性[1]。GTS 21 dihydrochloride也是α4β2 nAChR（Ki=20nM）和5-HT3A受体（IC50=3.1μM）的拮抗剂[2]。GTS 21 dihydrochloride可用于年龄相关记忆障碍、阿尔茨海默病、精神分裂症以及急性肺损伤等相关研究[3-4]。
在体外，GTS 21 dihydrochloride (3μM)预处理PC12细胞10分钟，随后以乙醇（100mM）刺激24小时，GTS 21 dihydrochloride显著减轻乙醇诱导的细胞毒性，并抑制细胞内钙离子浓度的异常升高[5]。GTS 21 dihydrochloride（3–10μM）预处理人肾小管上皮细胞（HK-2）30分钟，随后以LPS（10μg/ml）刺激24小时，GTS 21 dihydrochloride显著抑制NF-κB核转位及肾损伤标志物NGAL的表达，并降低趋化因子CCL20的分泌，从而减轻巨噬细胞向肾小管细胞的迁移浸润[6]。
在体内，GTS 21 dihydrochloride（4mg/kg）每日两次腹腔注射，持续8周，用于处理10-12周龄的Leprdb/db小鼠，显著改善肾功能指标包括血尿素氮（BUN）、肌酐，降低肾损伤标志物（KIM-1、NGAL）及炎症因子（IL-6、HMGB-1）水平，并减轻肾小球系膜基质扩张和细胞凋亡[7]。GTS 21 dihydrochloride（20mg/kg）单次腹腔注射15分钟前处理C57BL/6J，随后给予LPS（5mg/kg）腹腔注射诱导脓毒症急性肾损伤模型。GTS 21 dihydrochloride显著降低野生型小鼠血浆TNF-α水平、BUN及肾脏损伤标志物NGAL、KIM-1表达，并减少肾组织凋亡细胞数量[8]。
| Cell experiment [1]: | |
Cell lines | PC12 cells (rat pheochromocytoma cell line) |
Preparation Method | PC12 cells were cultured as described previously and maintained under standard conditions. Cells were treated with GTS 21 dihydrochloride (3μM) for 10min prior to ethanol (100mM) exposure for 24h. |
Reaction Conditions | 3μM; pretreatment for 10min |
Applications | GTS 21 dihydrochloride significantly attenuated ethanol-induced cytotoxicity in PC12 cells, reducing cell loss and suppressing the ethanol-triggered increase in intracellular calcium concentration. |
| Animal experiment [2]: | |
Animal models | Leprdb/db mice (model of type 2 diabetes and diabetic nephropathy) and db/+ control mice |
Preparation Method | Mice (10-12 weeks old) received GTS 21 dihydrochloride (4mg/kg) via intraperitoneal injection twice daily for 8 weeks. Control groups received vehicle. Kidney function, injury markers, and inflammatory cytokines were assessed post-treatment. |
Dosage form | 4mg/kg; i.p. |
Applications | GTS 21 dihydrochloride significantly ameliorated diabetic nephropathy by reducing plasma levels of BUN, creatinine, KIM-1, and NGAL, attenuating renal inflammation (IL-6 and HMGB-1), decreasing mitochondrial dysfunction (cytochrome C release), and suppressing apoptosis (cleaved caspase-3 and Bax). Histological analysis revealed reduced mesangial matrix expansion and glomerular injury. GTS 21 dihydrochloride also modulated signaling pathways by enhancing PI3K/AKT activity and inhibiting p38 MAPK activation. |
References: | |
| Cas No. | 156223-05-1 | SDF | |
| 别名 | (3E)-3-[(2,4-二甲氧基苯基)亚甲基]-3,4,5,6-四氢-2,3'-联吡啶二盐酸盐,DMXB-A; DMBX-anabaseine | ||
| 化学名 | (E)-3-(2,4-dimethoxybenzylidene)-3,4,5,6-tetrahydro-2,3'-bipyridine dihydrochloride | ||
| Canonical SMILES | COC1=CC(OC)=C(/C([H])=C2CCCN=C\2C3=CN=CC=C3)C=C1.Cl.Cl | ||
| 分子式 | C19H20N2O2.2HCl | 分子量 | 381.3 |
| 溶解度 | DMF: 1 mg/ml,DMSO: 2 mg/ml,Ethanol: 1 mg/ml,PBS (pH 7.2): 10 mg/ml | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.6226 mL | 13.113 mL | 26.2261 mL |
| 5 mM | 524.5 μL | 2.6226 mL | 5.2452 mL |
| 10 mM | 262.3 μL | 1.3113 mL | 2.6226 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet